Expression of defensins in gingiva and their role in periodontal health and disease.
Chung. W O WO; Dommisch. H H; Yin. L L; Dale. B A BA
Key Findings
- Oral epithelial cells produce the antimicrobial peptide LL‑37 and beta‑defensins.
- These peptides act against a wide range of microbes, including bacteria, yeast, and viruses.
- Both harmful and friendly microbes trigger signaling pathways that control peptide production, pointing to possible therapeutic targets.
Practical Outcomes
- While there’s no direct protocol to follow yet, supporting your oral microbiome and avoiding habits that damage the gum lining may help maintain natural LL‑37 and defensin levels. Future products might aim to boost these peptides locally for better gum health.
Summary
The paper shows that the cells lining your gums make natural antibiotics called LL‑37 and defensins, which help keep the mouth healthy by fighting bacteria, fungi, and viruses. Understanding how these peptides work could lead to new ways to prevent or treat gum disease, but the study doesn’t give a specific supplement or dosage to try now.
Abstract
Oral epithelium is a stratified squamous epithelium that functions as the barrier between the outside environment and the host. In the oral cavity, epithelial tissues are constantly exposed to a variety of bacteria, but most individuals maintain healthy homeostasis. Epithelial cells contribute to the innate host response, and antimicrobial peptide expression in all human epithelia, including oral epithelia, is an important part of this epithelial function. These antimicrobial peptides have a broad spectrum of activity against both Gram-negative and Gram-positive bacteria as well as against yeast and viruses. In humans these antimicrobial peptides include defensins and a cathelicidin family member LL-37 in skin and oral mucosa and other epithelia. The human defensins include the alpha-defensins of intestinal and neutrophil origin, and the beta-defensins of skin and oral mucosa and other epithelia. Present studies have identified specific signaling routes that pathogens and commensals take in stimulating these innate immune responses, and this may open the way for development of new therapeutic agents for periodontal diseases.
Study Information
pubmed
2007
2007-09-30T00:00:00.000Z
10.2174/138161207782110435
96